Income Statement
ANAPTYSBIO, INC
ANAB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
258.00 | 133.00 | 93.00 | 93.00 | 63.20 | 75.00 | 8.00 | - | 10.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - |
|
Gross Profit
|
258.00 | 133.00 | 93.00 | 93.00 | 63.20 | 75.00 | 8.00 | - | 10.00 |
|
Operating Expenses
|
186.71 | 206.23 | 181.57 | 125.44 | 119.99 | 98.88 | 115.43 | 71.72 | 38.78 |
|
Research & Development
|
139.61 | 163.84 | 132.28 | 88.80 | 98.50 | 80.03 | 99.34 | 56.20 | 29.44 |
|
Selling, General & Administrative
|
50.74 | 42.39 | 41.95 | 36.64 | 21.49 | 18.85 | 16.09 | 15.53 | 9.34 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - |
|
Operating Income
|
71.29 | -73.23 | -88.57 | -32.44 | -56.79 | -23.88 | -107.43 | -71.72 | -28.78 |
|
Non-Operating Income
|
12.92 | -30.28 | 0.79 | -13.55 | -0.98 | 3.95 | 9.94 | 4.87 | -1.29 |
|
Interest Income
|
13.50 | 19.79 | 18.87 | 7.55 | 0.43 | 3.96 | 10.98 | 6.69 | 1.62 |
|
Interest Expense
|
- | - | - | - | 0.00 | 0.00 | 1.04 | 1.65 | 1.78 |
|
Other Non-Op Income / Expense
|
5.45 | 0.01 | 0.00 | 0.01 | 0.04 | -0.01 | 0.00 | -0.16 | 0.23 |
|
Income Before Tax
|
153.02 | -145.23 | -163.62 | -128.70 | -57.80 | -19.93 | -97.49 | -61.85 | -30.07 |
|
Income Tax Expense
|
0.16 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | -0.15 | -0.19 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - |
|
Net Income
|
-13.23 | -145.23 | -163.62 | -128.72 | -57.80 | -19.93 | -97.34 | -61.66 | -30.07 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - |
|
EBITDA
|
71.85 | -72.62 | -87.92 | -31.77 | -56.17 | -23.32 | -106.92 | -71.41 | -28.60 |
|
Earnings Per Share (Basic)
|
-0.46 | -5.12 | -6.08 | -4.57 | -2.11 | - | -3.60 | -2.50 | -1.52 |
|
Diluted EPS
|
-0.46 | -5.12 | -6.08 | -4.57 | -2.11 | - | -3.60 | -2.50 | -1.52 |
|
Weighted Average Shares
|
28.76 | 28.38 | 26.92 | 28.17 | 27.43 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
28.76 | 28.38 | 26.92 | 28.17 | 27.43 | - | - | - | - |
|
Comprehensive Income
|
-13.56 | -144.13 | -159.17 | -133.55 | -58.21 | -20.27 | -96.78 | -61.45 | -30.50 |